These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 7740483

  • 1. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease.
    Kinlough-Rathbone RL, Perry DW, Packham MA.
    Thromb Haemost; 1995 Jan; 73(1):122-5. PubMed ID: 7740483
    [Abstract] [Full Text] [Related]

  • 2. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL, Perry DW, Rand ML, Packham MA.
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [Abstract] [Full Text] [Related]

  • 3. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide.
    Greco NJ, Jones GD, Tandon NN, Kornhauser R, Jackson B, Jamieson GA.
    Biochemistry; 1996 Jan 23; 35(3):915-21. PubMed ID: 8547273
    [Abstract] [Full Text] [Related]

  • 4. Effects of thrombin and the thrombin receptor activating peptide, SFLLRN, on redistribution of platelet alpha-granule contents are similar and independent of the extent of thromboxane formation.
    Suzuki H, Packham MA, Kinlough-Rathbone RL.
    Exp Mol Pathol; 1995 Feb 23; 62(1):63-72. PubMed ID: 7556592
    [Abstract] [Full Text] [Related]

  • 5. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC, Huang SW, Hwang TL, Kuo SC, Lee FY, Teng CM.
    Br J Pharmacol; 2000 Jul 23; 130(6):1289-96. PubMed ID: 10903968
    [Abstract] [Full Text] [Related]

  • 6. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A, Robson CA.
    J Pharmacol Exp Ther; 1997 May 23; 281(2):861-7. PubMed ID: 9152395
    [Abstract] [Full Text] [Related]

  • 7. Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by alpha-thrombin.
    Greco NJ, Tandon NN, Jones GD, Kornhauser R, Jackson B, Yamamoto N, Tanoue K, Jamieson GA.
    Biochemistry; 1996 Jan 23; 35(3):906-14. PubMed ID: 8547272
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML, Perry DW, Packham MA, Gemmell CH, Yeo EL, Kinlough-Rathbone RL.
    Am J Hematol; 1996 Aug 23; 52(4):288-94. PubMed ID: 8701947
    [Abstract] [Full Text] [Related]

  • 10. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides.
    Connolly TM, Condra C, Feng DM, Cook JJ, Stranieri MT, Reilly CF, Nutt RF, Gould RJ.
    Thromb Haemost; 1994 Oct 23; 72(4):627-33. PubMed ID: 7878643
    [Abstract] [Full Text] [Related]

  • 11. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL, Packham MA.
    Thromb Haemost; 1992 Aug 03; 68(2):189-93. PubMed ID: 1412166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of neutral proteases from blood leukocytes on human platelets.
    Bykowska K, Kaczanowska J, Karpowicz M, Stachurska J, Kopeć M.
    Thromb Haemost; 1983 Dec 30; 50(4):768-72. PubMed ID: 6320486
    [Abstract] [Full Text] [Related]

  • 14. Different abilities of thrombin receptor activating peptide and thrombin to induce platelet calcium rise and full release reaction.
    Lasne D, Donato J, Falet H, Rendu F.
    Thromb Haemost; 1995 Nov 30; 74(5):1323-8. PubMed ID: 8607117
    [Abstract] [Full Text] [Related]

  • 15. Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein GPIb.
    Peng M, Emig FA, Mao A, Lu W, Kirby EP, Niewiarowski S, Kowalska MA.
    Thromb Haemost; 1995 Sep 30; 74(3):954-7. PubMed ID: 8571328
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interaction of von Willebrand factor with platelets activated by thrombin or a synthetic 7-amino acid peptide derived from the cleaved thrombin receptor.
    Minckes O, Freyssinet JM, Rouault C, Pavirani A, Rasmussen U, Boyer-Neumann C, Meyer D, Girma JP.
    C R Acad Sci III; 1994 Apr 30; 317(4):363-70. PubMed ID: 8000916
    [Abstract] [Full Text] [Related]

  • 18. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
    Holme PA, Solum NO, Brosstad F, Egberg N, Lindahl TL.
    Thromb Haemost; 1995 Dec 30; 74(6):1533-40. PubMed ID: 8772233
    [Abstract] [Full Text] [Related]

  • 19. ADP-dependence of platelet activation induced by a thrombin receptor agonist.
    Savi P, Dol F, Herbert JM.
    Nouv Rev Fr Hematol (1978); 1993 Apr 30; 35(2):115-9. PubMed ID: 8392699
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.